These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36262899)

  • 1. Recurrence of Thrombotic Thrombocytopenic Purpura After Vaccination with mRNA-1273 COVID-19 vaccine.
    Ntelis S; Champ K
    J Community Hosp Intern Med Perspect; 2022; 12(4):80-84. PubMed ID: 36262899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine - case report.
    Osmanodja B; Schreiber A; Schrezenmeier E; Seelow E
    BMC Nephrol; 2021 Dec; 22(1):411. PubMed ID: 34895163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic thrombocytopenic purpura following ChAdOx1 nCov-19 vaccination: A case report.
    Shateri Amiri B; Radkhah H; Taslimi R; Shahbazi Dastjerdi Z; Khadembashiri MM; Gholizadeh Mesgarha M; Rahimipour Anaraki S
    IDCases; 2023; 32():e01795. PubMed ID: 37214181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic Thrombocytopenic Purpura After Ad6.COV2.S Vaccination.
    Ramanan S; Singh H; Menon P; Patel PM; Parmar V; Malik D
    Cureus; 2022 Aug; 14(8):e28592. PubMed ID: 36185943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic thrombocytopenic purpura developed after pegylated interferon treatment for hepatitis B infection.
    Mei S; Feng Y; Cui L; Chen J; Mao Z; Zhao X; Mei C; Qian Y
    BMC Nephrol; 2022 Dec; 23(1):400. PubMed ID: 36513992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Value of Schistocytes in Recurrence of Acquired Thrombotic Thrombocytopenic Purpura With Severe ADAMTS13 Deficiency at Discontinuation of Daily Therapeutic Plasma Exchange.
    Peedin AR; Park YA; Mazepa MA; Rollins-Raval MA; Brecher ME; Raval JS
    Ther Apher Dial; 2018 Dec; 22(6):662-665. PubMed ID: 30178615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine.
    Waqar SHB; Khan AA; Memon S
    Int J Hematol; 2021 Nov; 114(5):626-629. PubMed ID: 34264514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired Thrombotic Thrombocytopenic Purpura Following Inactivated COVID-19 Vaccines: Two Case Reports and a Short Literature Review.
    Ben Saida I; Maatouk I; Toumi R; Bouslama E; Ben Ismail H; Ben Salem C; Boussarsar M
    Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of Thrombotic Thrombocytopenic Purpura after mRNA-1273 COVID-19 Vaccine Administered Shortly after COVID-19.
    Karabulut K; Andronikashvili A; Kapici AH
    Case Rep Hematol; 2021; 2021():4130138. PubMed ID: 34552799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired thrombotic thrombocytopenic purpura after AstraZeneca vaccine: A case report.
    Yaghoubi F; Dalil D
    Caspian J Intern Med; 2022; 13(Suppl 3):299-302. PubMed ID: 35872667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired Thrombotic Thrombocytopenic Purpura Following BNT162b2 mRNA Coronavirus Disease Vaccination in a Japanese Patient.
    Yoshida K; Sakaki A; Matsuyama Y; Mushino T; Matsumoto M; Sonoki T; Tamura S
    Intern Med; 2022 Feb; 61(3):407-412. PubMed ID: 34803105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Rare Case of Severe Manifestation of COVID-19 Infection Presenting as Immune-Related Thrombotic Thrombocytopenic Purpura With Multiorgan Involvement Treated With Plasmapheresis, Steroids, Rituximab, and Caplacizumab.
    Mandyam S; Fatmi SS; Banzon G; Kaur P; Katamreddy Y; Parghi D; Farooq A; Liaqat H; Basarakodu K
    Cureus; 2022 Jul; 14(7):e26961. PubMed ID: 35989829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nivolumab-Induced Thrombotic Thrombocytopenic Purpura in a Patient with Anal Squamous Cell Carcinoma: A Lesson on Hematologic Toxicity from Immunotherapy.
    Gergi M; Landry KK; Ades S; Barry M; Zakai NA; Herrera DA
    Oncologist; 2020 Dec; 25(12):1009-1012. PubMed ID: 33017484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.
    Shenkman B; Einav Y
    Autoimmun Rev; 2014; 13(4-5):584-6. PubMed ID: 24418304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic thrombocytopenic purpura developed during the conservative treatment of anti-phospholipase A
    Iio R; Akiyama S; Mitsumoto K; Iwata Y; Okushima H; Shimada K; Ota N; Tomida K; Fushimi H; Shoji T; Matsumoto M; Hayashi T
    BMC Nephrol; 2020 Oct; 21(1):431. PubMed ID: 33046023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic Thrombocytopenic Purpura Presentation in an Elderly Gentleman Following COVID Vaccine Circumstances.
    Chamarti K; Dar K; Reddy A; Gundlapalli A; Mourning D; Bajaj K
    Cureus; 2021 Jul; 13(7):e16619. PubMed ID: 34447649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First report of a de novo iTTP episode associated with an mRNA-based anti-COVID-19 vaccination.
    de Bruijn S; Maes MB; De Waele L; Vanhoorelbeke K; Gadisseur A
    J Thromb Haemost; 2021 Aug; 19(8):2014-2018. PubMed ID: 34105244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe HELLP syndrome masquerading as thrombocytopenic thrombotic purpura: a case report.
    Mousseaux C; Joly BS; Mohamadou I; Arrestier R; Hertig A; Rafat C
    BMC Nephrol; 2020 May; 21(1):204. PubMed ID: 32471388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of severe ADAMTS13 deficiency presenting as thrombotic thrombocytopenic purpura in pregnancy.
    Nikolaou M; Karakantza M; Adonakis G; Theodorou G; Zoumbos N; Decavalas G
    Med Pregl; 2012; 65(9-10):436-9. PubMed ID: 23214340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
    Shibagaki Y; Fujita T
    Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.